BacVax Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

BacVax General Information

Description

Developer of vaccines designed to target bacterial infections for which few or no effective vaccines exist. The company utilizes a bioinformatics-driven structural vaccinology approach that identifies conserved surface proteins and delivers them via a proprietary bacterial vaccine polypeptide platform, enabling healthcare providers to prevent bacterial infections, reduce reliance on antibiotics, and target multiple bacterial strains safely.

Contact Information

Website
www.bacvax.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Phoenix, AZ
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Parent Company
Vertical(s)
Corporate Office
  • Phoenix, AZ
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BacVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Oct-2025 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
1. University Spin-Out 01-Jan-2021 Completed Generating Revenue
To view BacVax’s complete valuation and funding history, request access »

BacVax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BacVax Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arizona State University University
Tech Launch Arizona Accelerator/Incubator
University of Arizona University
To view BacVax’s complete investors history, request access »

BacVax FAQs

  • When was BacVax founded?

    BacVax was founded in 2021.

  • Where is BacVax headquartered?

    BacVax is headquartered in Phoenix, AZ.

  • What is the size of BacVax?

    BacVax has 3 total employees.

  • What industry is BacVax in?

    BacVax’s primary industry is Drug Discovery.

  • Is BacVax a private or public company?

    BacVax is a Private company.

  • What is BacVax’s current revenue?

    The current revenue for BacVax is .

  • Who are BacVax’s investors?

    Arizona State University, Tech Launch Arizona, and University of Arizona have invested in BacVax.

  • When was BacVax acquired?

    BacVax was acquired on 27-Oct-2025.

  • Who acquired BacVax?

    BacVax was acquired by GPN Vaccines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process